Monthly Archives: September 2014

Stem Cells are Important – Video

Posted: September 11, 2014 at 8:49 am


Stem Cells are Important
This is a video PSA for Mrs. Roper #39;s 3rd period CPAmlit class. By Ahmed Benabdesselam, Phillip Brent, Zachary Kennedy, and Steele Parson.

By: Phillip Brent

See more here:
Stem Cells are Important - Video

Posted in Stem Cell Videos | Comments Off on Stem Cells are Important – Video

Stem Cell Transplant – Stem Cell Transplant Process – Video

Posted: September 11, 2014 at 8:49 am


Stem Cell Transplant - Stem Cell Transplant Process
Stem Cell Transplant - Stem Cell Transplant Process http://goo.gl/zXSEK6 Stem cells form one of the most basic and important ingredient from the human system. They may be effective at differentiat...

By: Angus Parker

Read more here:
Stem Cell Transplant - Stem Cell Transplant Process - Video

Posted in Stem Cell Research | Comments Off on Stem Cell Transplant – Stem Cell Transplant Process – Video

Programme Your BODY & MIND to REVERSE AGING with Stephen Hawking on Science Channel – Video

Posted: September 11, 2014 at 1:52 am


Programme Your BODY MIND to REVERSE AGING with Stephen Hawking on Science Channel
"STEM CELL UNIVERSE" with Stephen Hawking Stephen Hawking, Science Channel presents a controversial and groundbreaking new special STEM CELL UNIVERSE with Stephen Hawking premiering on Monday,...

By: Tricia Kwa

Link:
Programme Your BODY & MIND to REVERSE AGING with Stephen Hawking on Science Channel - Video

Posted in Stem Cells | Comments Off on Programme Your BODY & MIND to REVERSE AGING with Stephen Hawking on Science Channel – Video

Fibroblast Growth Factor FGF & Stem Cells – Video

Posted: September 11, 2014 at 1:52 am


Fibroblast Growth Factor FGF Stem Cells

By: TEAM ABSUCCESS

Originally posted here:
Fibroblast Growth Factor FGF & Stem Cells - Video

Posted in Stem Cells | Comments Off on Fibroblast Growth Factor FGF & Stem Cells – Video

Induced Stem Cells Will Be Tested on Humans for the First Time

Posted: September 11, 2014 at 1:52 am

Back in 2006, when controversy over embryonic stem cell funding was still raging, a piece of research came along that would make the debate essentially obsolete: normal adult cells can actually be reprogrammed into stem cells. No embryos necessary. The technique went on to win its inventor the Nobel Prize. And now, after many years in the lab, a Japanese patient will the first person to receive the next-gen treatment, called induced pluripotent stem cells.

This first clinical trial for iPSCs has long been in the making. Part of its complexity is that cells are taken from each patient and then, through a series of lab procedures, transformed into stem cells. Each patient gets his or her own genetically matched iPSCs.

This individualization is a key advantage over embryonic stem cells, which have been tested in humans before. Special drugs are required to prevent patients' bodies from rejecting embryonic stem cells.

After some final safety checks and genetic tests, the first clinical trial is officially underway in Japan. Nature reports that the first patient will likely receive iPSCs within days. In total, the clinical trial has enrolled six patients, all of whom with an eye condition called macular degeneration that leads to blindness. The iPSCs will replace a deteriorated layer of cells in their retinas.

So far, the procedure has worked without serious adverse effects (usually tumors) in mice and monkeys. If it works in humans, iPSCs could be a promising new avenue for human stem cell therapy, which, if you remember, could hold the key to all sorts of incurable conditions from diabetes to Parkinson's to spinal cord injuries. This is a small first step in that direction. [Nature]

Top image: an eye with signs of macular degeneration. National Eye Institute

Read the original:
Induced Stem Cells Will Be Tested on Humans for the First Time

Posted in Stem Cells | Comments Off on Induced Stem Cells Will Be Tested on Humans for the First Time

Tory Williams combats controversy surrounding stem cell therapy with new book

Posted: September 11, 2014 at 1:50 am

PUBLIC RELEASE DATE:

10-Sep-2014

Contact: Melanie Scharler 917-340-6492 Mary Ann Liebert, Inc./Genetic Engineering News @LiebertOnline

(New Rochelle, New York) September 10, 2014 - Mary Ann Liebert, Inc., leading publisher of over 80 science, technology, and medical publications, announced today the launch of first time hard cover title Inevitable Collision: The Inspiring Story that Brought Stem Cell Research to Conservative America, in an effort to bring awareness to the growing conversation and debate surrounding stem cell research and regenerative medicine.

Written by Tory Williams, author, advocate, mom, and co-founder of the Alabama Institute of Medicine (AIM), Inevitable Collision is a human-interest story that details the controversial Geron Trial, the first human embryonic stem cell trial for patients with paralysis, and thoughtfully documents the first and fifth patients, TJ Atchison and Katie Sharify. The book features provocative conversations with doctors, medical researchers, and scientists including Dr. Hans Keirstead, the famous scientist whose groundbreaking research helped rats to overcome paralysis through stem cell treatments and introduced the therapy to humans, and helps inform the public conversation by presenting the facts and opportunities surrounding stem cell research and therapy.

"Tory's personal journey of advocacy, perseverance, and commitment to the advance-ment of stem cell research and its application is an important and relevant testament to the stem cell conversation at large," said Mary Ann Liebert, president and CEO of the company that bears her name. "Inevitable Collision will strongly resonate with the six million Americans suffering from paralysis, a quarter of which are the result of a spinal cord injury. In a very readable and compelling style, Williams has brought the much needed human voice to the oftentimes controversial and misunderstood topic of stem cell technology. It is an important read for the public, legislators, and patients and their families, as well as for researchers and members of the health care community. This book will make a difference!"

Compared to the narrative and journalistic writing style of The Immortal Life of Henrietta Lacks, Inevitable Collision explains in reader-friendly terms how stem cells work, and why they are considered important tools in finding a cure for paralysis and other disabilities. The book also details author Tory Williams' physical and emotional struggles while raising funding and public awareness surrounding embryonic stem cell research across the nation.

"Through this book I hope to bridge the gap between science and religion and raise awareness of the importance and power of stem cell research," said Tory Williams. "This book is intended not only for patients who suffer from paralysis and diseases such as cancer and Parkinson's, but for everyone affected by these afflictions, directly and indirectly."

The launch comes on the heels of the California Institute for Regenerative Medicine's (CIRM) recent announcement green lighting the follow-up phase to the Geron clinical trial as approved by the FDA.

Inevitable Collision's 208 pages plus 8-page photo spread retails at $21.95 for the hard-back and $9.99 for the e-book and includes an afterword written by Roman Reed, a tire-less patient advocate who was paralyzed from a sports injury 20 years ago. Roman is the Founder of the Roman Reed Foundation and Roman's Law, which was the impetus for California's groundbreaking stem cell program.

Read more:
Tory Williams combats controversy surrounding stem cell therapy with new book

Posted in Genetic Engineering | Comments Off on Tory Williams combats controversy surrounding stem cell therapy with new book

Clinical Trial to Test Safety of Stem Cell-Derived Therapy for Type 1 Diabetes

Posted: September 11, 2014 at 1:48 am

Contact Information

Available for logged-in reporters only

Newswise Researchers at the University of California, San Diego School of Medicine, in partnership with ViaCyte, Inc., a San Diego-based biotechnology firm specializing in regenerative medicine, have launched the first-ever human Phase I/II clinical trial of a stem cell-derived therapy for patients with Type 1 diabetes.

The trial will assess the safety and efficacy of a new investigational drug called VC-01, which was recently approved for testing by the U.S. Food and Drug Administration. The 2-year trial will involve four to six testing sites, the first being at UC San Diego, and will recruit approximately 40 study participants.

The goal, first and foremost, of this unprecedented human trial is to evaluate the safety, tolerability and efficacy of various doses of VC-01 among patients with type 1 diabetes mellitus, said principal investigator Robert R. Henry, MD, professor of medicine in the Division of Endocrinology and Metabolism at UC San Diego and chief of the Section of Endocrinology, Metabolism & Diabetes at the Veterans Affairs San Diego Healthcare System. We will be implanting specially encapsulated stem cell-derived cells under the skin of patients where its believed they will mature into pancreatic beta cells able to produce a continuous supply of needed insulin. Previous tests in animals showed promising results. We now need to determine that this approach is safe in people.

Development and testing of VC-01 is funded, in part, by the California Institute for Regenerative Medicine, the states stem cell agency, the UC San Diego Sanford Stem Cell Clinical Center and JDRF, the leading research and advocacy organization funding type 1 diabetes research.

Type 1 diabetes mellitus is a life-threatening chronic condition in which the pancreas produces little or no insulin, a hormone needed to allow glucose to enter cells to produce energy. It is typically diagnosed during childhood or adolescence, though it can also begin in adults. Though far less common than Type 2 diabetes, which occurs when the body becomes resistant to insulin, Type 1 may affect up to 3 million Americans, according to the JDRF. Among Americans age 20 and younger, prevalence rose 23 percent between 2000 and 2009 and continues to rise. Currently, there is no cure. Standard treatment involves daily injections of insulin and rigorous management of diet and lifestyle.

Phase I/II clinical trials are designed to assess basic safety and efficacy of therapies never before tested in humans, uncovering unforeseen risks or complications. Unpredictable outcomes are possible. Such testing is essential to ensure that the new therapy is developed responsibly with appropriate management of risks that all medical treatments may present.

This is not yet a cure for diabetes, said Henry. The hope, nonetheless, is that this approach will ultimately transform the way individuals with Type 1 diabetes manage their disease by providing an alternative source of insulin-producing cells, potentially freeing them from daily insulin injections or external pumps.

This clinical trial at UC San Diego Health System was launched and supported by the UC San Diego Sanford Stem Cell Clinical Center. The Center was recently created to advance leading-edge stem cell medicine and science, protect and counsel patients, and accelerate innovative stem cell research into patient diagnostics and therapy.

See the article here:
Clinical Trial to Test Safety of Stem Cell-Derived Therapy for Type 1 Diabetes

Posted in Stem Cell Therapy | Comments Off on Clinical Trial to Test Safety of Stem Cell-Derived Therapy for Type 1 Diabetes

Anti Aging Skin Care – Jeunesse Stem Cell Rejuvenation – Video

Posted: September 10, 2014 at 7:43 pm


Anti Aging Skin Care - Jeunesse Stem Cell Rejuvenation
http://skincarebusiness.co/ http://skincare.mybigcommerce.com/ Promote new cell growth New cell growth is an essential part of lifeit #39;s how we grow from child to adult. But as we age...

By: Skin Care and Anti Aging Supplements

See the article here:
Anti Aging Skin Care - Jeunesse Stem Cell Rejuvenation - Video

Posted in Stem Cell Videos | Comments Off on Anti Aging Skin Care – Jeunesse Stem Cell Rejuvenation – Video

Fibroblast Growth Factor FGF & Stem Cells – Video

Posted: September 10, 2014 at 7:43 pm


Fibroblast Growth Factor FGF Stem Cells

By: TEAM ABSUCCESS

Originally posted here:
Fibroblast Growth Factor FGF & Stem Cells - Video

Posted in Stem Cell Videos | Comments Off on Fibroblast Growth Factor FGF & Stem Cells – Video

Mississippi Stem Cell Treatment Center – Stem Cell Center …

Posted: September 10, 2014 at 1:52 pm

Excellence With a Human Touch

Mississippi Stem Cell Treatment Center is an affiliate of the Cell Surgical Network. Since 2010, the renowned Cell Surgical Network has been known for the investigational use of stem cell deployments for degenerative conditions. Using international technology, we have developed a closed surgical method to isolatea cellular medium (SVF), which isrich in stem cells. At our stem cell center, we emphasize quality and are highly committed to clinical research and the advancement of regenerative medicine.

Treatments Include: Orthopedic Treatment Neurological Treatment Cardiac Treatment Autoimmune Disease Treatment Erectile Dysfunction Treatment Lichen Sclerosis Treatment

Dr.Barmada began his medical career in 1974, when he graduated from Manchester University Medical School in the UK. In Summer 2011, Dr. Barmada decided to dedicate more time to his enlarging venous practice. Dr. Barmada also developed an interest in aesthetics, as well as the use of stem cells for the treatment of many inoperable conditions he encountered over the years, including vascular occlusions, severe COPD and heart conditions. Dr. Barmadapossesses active medical licenses in Mississippi and Louisiana. Dr. Barmada alsohas two US patentswitha thirdUS patentpending.

Dr. Suzanne Rinno is amedical biochemist who has spent many years working as a medical office administrator. Dr. Rinnoreceived her PhD from Manchester Medical School in the United Kingdom. Dr.Rinno worked as a Research Assistant and as a Post Doctorate Fellow at Manchester Medical School in England, and later as part of the Medical Staff for the University of Aleppo Medical School. More recently she was a Post Doctorate Fellow at the Oregon Science University in Portland, OR. She is currently the Director of Stem Cell Technology at theMississippi Stem Cell Treatment Centerin Ocean Springs, MS.

Stromal Vascular Fraction (SVF), which is rich in stem cells and growth factors, uses a patients own stem cells to promote healing and tissue regeneration. SVFs are collected from a patients fat tissue and minimally processed before being injected back into the patient at the treatment site. Because a stem cell is a special type of cell that can turn into any other type of cell and multiply, SVF can be used to regrow many different tissues including skin, collagen, and cartilage throughout the body.

See original here:
Mississippi Stem Cell Treatment Center - Stem Cell Center ...

Posted in Mississippi Stem Cells | Comments Off on Mississippi Stem Cell Treatment Center – Stem Cell Center …